XM nie świadczy usług obywatelom Stanów Zjednoczonych.
M
M

McCormick


Wiadomości

Tesla investors to urge judge to reject record $7 bln legal fee in Musk pay case

Tesla investors to urge judge to reject record $7 bln legal fee in Musk pay case By Tom Hals WILMINGTON, Delaware, July 8 (Reuters) - Tesla shareholders will appear in court on Monday to argue that an unprecedented request for more than $7 billion in attorneys' fees to be paid by the company is "outlandish," the latest twist in a legal showdown over Musk's $56 billion pay package.
T
D
M

U.S. Alphabet, Equity Residential, Infinera

U.S. RESEARCH ROUNDUP-Alphabet, Equity Residential, Infinera June 28 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Alphabet, Equity Residential and Infinera, on Friday. HIGHLIGHTS * Alphabet Inc GOOGL.O : Rosenblatt Securities cuts to neutral from buy * American Financial Group Inc AFG.N : Citigroup cuts to neutral from buy * Cincinnati Financial Corp CINF.O : Citigroup raises to buy from neutral * Equity Residenti
A
A
A
C
C
C
G
G
H
N
P
W
D
P
C
A
G
H
L
M

S&P 500 top and bottom performing stocks at about 03:30 p.m. EDT

BUZZ - S&P 500 top and bottom performing stocks at about 03:30 p.m. EDT S&P 500 .SPX Top Performers Percent Change Super Micro Computer Inc SMCI.OQ +6.7% Palo Alto Networks Inc PANW.OQ +5.6% Arista Networks Inc ANET.N +4.2% Salesforce Inc CRM.N +4.1% McCormick & Company Inc MKC.N +3.7% Bottom Performers Percent Change Walgreens Boots Alliance Inc W
C
M
S
W
U
A
M

U.S. STOCKS Tempus AI, AeroVironment, Gold miners

BUZZ-U.S. STOCKS ON THE MOVE-Tempus AI, AeroVironment, Gold miners Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 U.S. stock indexes were flat on Thursday, as investors assessed a string of economic data ahead of the Federal Reserve's closely watched inflation report, while Micron and pharmacy chain Walgreens Boots Alliance slumped on disappointing forecasts.
B
G
H
M
N
S
W
U
U
T
C
M

S&P 500 top and bottom performing stocks at about 12:00 p.m. EDT

BUZZ - S&P 500 top and bottom performing stocks at about 12:00 p.m. EDT S&P 500 .SPX Top Performers Percent Change Salesforce Inc CRM.N +5.3% Palo Alto Networks Inc PANW.OQ +4.4% McCormick & Company Inc MKC.N +4.2% Super Micro Computer Inc SMCI.OQ +3.8% Adobe Inc ADBE.OQ +3.4% Bottom Performers Percent Change Walgreens Boots Alliance Inc WBA.OQ -24
A
C
M
S
W
U
M

U.S. STOCKS Verona Pharma, McCormick, gold miners

BUZZ-U.S. STOCKS ON THE MOVE-Verona Pharma, McCormick, gold miners Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 The Nasdaq slightly fell while other indexes were flat to slightly higher on Thursday, as a dip in Treasury yields after a string of economic data boosted megacap stocks.
B
G
H
M
S
W
U
U
T
M

McCormick up after upbeat quarterly results on strong EMEA business

BUZZ-McCormick up after upbeat quarterly results on strong EMEA business ** Shares of hot sauce maker McCormick MKC.N up as much as 6.4% at $72 in early trading ** Stock snaps two sessions of losses, set for best day since March 2024 ** Co beats quarterly sales and profit estimates owing to strong demand for its spices and seasonings in Europe, Middle East and Africa (EMEA) ** Posts Q2 sales of $1.64 bln vs LSEG estimates of $1.63 bln ** Reports 5% rise in EMEA business of consumer segment, driv
M

Spice maker McCormick beats quarterly results on strong EMEA business

Spice maker McCormick beats quarterly results on strong EMEA business June 27 (Reuters) - McCormick MKC.N beat market expectations for second-quarter profit and sales on Thursday, led by strong demand for its spices and seasonings in Europe, Middle East and Africa. Customers grappling with still-high costs preferred cooking at home to dining out , improving volumes across the company's consumer segment, its biggest unit.
M

McCormick & Company Q2 Adjusted EPS USD 0.69 Vs. Estimate USD 0.61

BRIEF-McCormick & Company Q2 Adjusted EPS USD 0.69 Vs. Estimate USD 0.61 Jun 27 (Reuters) - McCormick & Company Q2 operating income USD 234 million. Q2 EPS USD 0.68 Q2 adjusted operating income USD 236 million vs. estimate USD 236.4 million outlook FY adjusted EPS USD 2.8-2.85 outlook FY EPS USD 2.76-2.81
M

Mccormick Announces Marcos Gabriel To Become Executive VP & CFO And Planned Retirement Of Mike Smith

BRIEF-Mccormick Announces Marcos Gabriel To Become Executive VP & CFO And Planned Retirement Of Mike Smith McCormick & Company Inc MKC.N : MCCORMICK ANNOUNCES MARCOS GABRIEL TO BECOME EXECUTIVE VP & CFO AND PLANNED RETIREMENT OF MIKE SMITH Source text for Eikon: ID:nPn9fBFz3a Further company coverage: MKC.N
M

McCormick names insider Marcos Gabriel as CFO

UPDATE 1-McCormick names insider Marcos Gabriel as CFO Adds details in paragraph 1 and 2 June 26 (Reuters) - Cholula hot sauce maker McCormick & Company MKC.N said on Wednesday it has named company insider Marcos Gabriel as its chief financial officer effective Dec. 1 . Current CFO Mike Smith, who has been at the designation since 2016, there on will continue with the company as Executive Vice President until his retirement on Feb.
M

McCormick & Company names insider Marcos Gabriel as CFO

McCormick & Company names insider Marcos Gabriel as CFO June 26 (Reuters) - McCormick & Company MKC.N said on Wednesday it has named company insider Marcos Gabriel as its chief financial officer. Reporting by Tanay Dhumal in Bengaluru; Editing by Alan Barona
M

What to Watch in the Day Ahead - Thursday, June 27

What to Watch in the Day Ahead - Thursday, June 27 The Day Ahead is an email and PDF publication that includes the day's major stories and events, analyses and other features. To receive The Day Ahead, Eikon users can register at DAY/US . Thomson One users can register at RT/DAY/US. All times in ET/GMT On the U.S. economic calendar, the Commerce Department's Bureau of Economic Analysis is expected to report in its final estimate that the gross domestic product likely grew at 1.3% annualized rate
N
W
M

McCormick & Company Inc <MKC.N> expected to post earnings of 59 cents a share - Earnings Preview

McCormick & Company Inc expected to post earnings of 59 cents a share - Earnings Preview McCormick & Company Inc MKC.N , MKC is expected to show a fall in quarterly revenue when it reports results on June 27 for the period ending May 31 2024 The Hunt Valley Maryland-based company is expected to report a 1.7% decrease in revenue to $1.632 billion from $1.66 billion a year ago, according to the mean estimate from 11 analysts, based on LSEG data.
M

What to Watch in the Week Ahead and on Monday, June 24

What to Watch in the Week Ahead and on Monday, June 24 The Day Ahead is an email and PDF publication that includes the day's major stories and events, analyses and other features. To receive The Day Ahead, Eikon users can register at DAY/US . Thomson One users can register at RT/DAY/US. All times in ET/GMT ON MONDAY Federal Reserve Bank of San Francisco President Mary Daly will likely speak on monetary policy and the economy at an event in partnership with the Commonwealth Club World Affairs of
N
T
W
M

U.S. earnings week ahead

DIARY-U.S. earnings week ahead June 21 (Reuters) - Diary of U.S. (.SPX) corporate earnings for the week ahead. ** Please Note - All times given are in U.S. EDT unless otherwise stated ** U.S. EARNINGS Start Date Start Time (GMT) RIC Company Name Event Name 25-Jun-2024 AMC FDX FedEx Corp Q4 2024 FedEx Corp Earnings Release 25-Jun-2024 AMC JNPR Juniper Networks Inc Q2 2024 Preliminary Juniper Networks Inc Earnings Release 26-Jun-2024 AMC MU.O Micron Technology Inc Q3 2024 Micron Technology Inc Ear
M
N
P
W
U
M

U.S. Aerovate Therapeutics, Boeing, Wingstop

U.S. RESEARCH ROUNDUP-Aerovate Therapeutics, Boeing, Wingstop June 18 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Aerovate Therapeutics, Boeing and Wingstop, on Tuesday. HIGHLIGHTS * Aerovate Therapeutics Inc AVTE.O : TD Cowen cuts to hold from buy * Boeing BA.N : RBC cuts target price to $210 from $215 * Mirum Pharmaceuticals Inc MIRM.O : Evercore ISI raises target price to $62 from $53 * Transdigm Group Inc TDG
A
B
K
M
N
C
C
D
M

U.S. Aerovate Therapeutics, Boeing, Wingstop

U.S. RESEARCH ROUNDUP-Aerovate Therapeutics, Boeing, Wingstop June 18 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Aerovate Therapeutics, Boeing and Wingstop, on Tuesday. HIGHLIGHTS * Aerovate Therapeutics Inc AVTE.O : TD Cowen cuts to hold from buy * Boeing BA.N : RBC cuts target price to $210 from $215 * Mirum Pharmaceuticals Inc MIRM.O : Evercore ISI raises target price to $62 from $53 * Transdigm Group Inc TDG
A
B
K
M
N
U
T
C
C
D
M

U.S. BioNTech, Honeywell International, Klaviyo

U.S. RESEARCH ROUNDUP-BioNTech, Honeywell International, Klaviyo June 12 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Biontech, Honeywell International and Klaviyo, on Wednesday. HIGHLIGHTS * BioNTech SE BNTX.O : JP Morgan raises target price to $94 from $90 * Honeywell International Inc HON.O : HSBC raises target price to $235 from $200 * Klaviyo Inc KVYO.N : Barclays raises to overweight from equal weight * NetA
A
F
G
N
R
G
D
M

Mccormick Appoints Valarie Sheppard To Board Of Directors

BRIEF-Mccormick Appoints Valarie Sheppard To Board Of Directors May 21 (Reuters) - McCormick & Company Inc MKC.N : MCCORMICK APPOINTS VALARIE SHEPPARD TO BOARD OF DIRECTORS Source text for Eikon: ID:nPn3mWK4Za Further company coverage: MKC.N
M



Warunki

Popularne aktywa

Wyłączenie odpowiedzialności: Każdy z podmiotów należących do XM Group świadczy usługę polegającą wyłącznie na realizacji zleceń i dostępie do naszej internetowej platformy transakcyjnej, umożliwiając danej osobie przeglądanie i/lub korzystanie z treści dostępnych na stronie lub za jej pośrednictwem, co nie ma na celu zmiany lub rozszerzenia tego zakresu, ani nie zmienia i nie rozszerza go. Taki dostęp i korzystanie z niego podlegają w każdej chwili: (i) Warunkom umowy, (ii) Ostrzeżeniom o ryzyku i (iii) Pełnemu wyłączeniu odpowiedzialności. Treści te są zatem podawane wyłącznie jako informacje ogólne. W szczególności należy pamiętać, że treści zawarte na naszej internetowej platformie transakcyjnej nie stanowią oferty ani zaproszenia do zawarcia jakichkolwiek transakcji na rynkach finansowych. Transakcje na każdym rynku finansowym wiążą się ze znacznym poziomem ryzyka dla twojego kapitału.

Wszystkie materiały publikowane na naszej internetowej platformie transakcyjnej są przeznaczone wyłącznie do celów edukacyjnych/informacyjnych i nie zawierają – i nie powinny być uważane za zawierające – porad ani rekomendacji dotyczących finansów, inwestycji, podatków lub transakcji, zapisu naszych cen transakcyjnych, ani też oferty lub zaproszenia do transakcji na jakichkolwiek instrumentach lub niezamówionych promocji finansowych.

Wszelkie treści pochodzące od podmiotów trzecich, jak i treści przygotowane przez XM, takie jak opinie, wiadomości, badania, analizy, ceny i inne informacje lub linki do stron podmiotów trzecich zawarte na tej stronie internetowej są udostępniane na zasadzie „tak, jak jest” jako ogólny komentarz rynkowy i nie stanowią porady inwestycyjnej. W zakresie, w jakim jakakolwiek treść jest interpretowana jako badania inwestycyjne, należy zauważyć i zaakceptować, że treść ta nie była przeznaczona i nie została przygotowana zgodnie z wymogami prawnymi mającymi na celu promowanie niezależności badań inwestycyjnych i jako taka byłaby uważana za komunikat marketingowy w świetle odpowiednich przepisów prawnych i regulacji. Upewnij się, że przeczytałeś(-aś) i rozumiesz nasze dokumenty Powiadomienie o zależnych badaniach inwestycyjnych oraz Ostrzeżenie o ryzyku, dotyczące powyższych informacji, do których można uzyskać dostęp tutaj.

Ostrzeżenie o ryzyku: Twój kapitał jest zagrożony. Produkty z zastosowaniem dźwigni mogą nie być odpowiednie dla każdego inwestora. Zapoznaj się z Ujawnieniem ryzyka.